News from REMEDY

Diakonhjemmet Hospital is among the six hospitals that conduct the most research in Norway. Many of the studies are clinical research.

Let's get LinkedIn up and running for the REMEDY Center!

The driver for increasing size and reach is people liking and sharing. If you have the opportunity to click on LinkedIn, you can share the story in English. There is also a Norwegian version that can be shared.

The healthcare sector is responsible for large greenhouse gas emissions. Now two leading research groups in Norway are taking an international initiative to calculate the climate footprint in advance of medical treatments. The goal is to offer healthcare services that are beneficial for both the patient and the planet. These ambitions have recently been published in the highest ranked medical journal internationally, The New England Journal of Medicine. 

The doctoral thesis shows a connection between the patient's immune response and the effect of treatment in inflammatory diseases of the joints and intestines. The research has contributed to a greater understanding of how the immune system affects the effect of biological medicines and COVID-19 vaccines in people with such diseases.

Join the MAGIC Evidence Ecosystem Foundation for the Conference on Evidence-Based Medicine and AI to explore the implications for healthcare policy and practice in Norway.

- We are thrilled to invite you to register for an exciting and insightful conference exploring the synergy between Evidence-Based Medicine (EBM) and Artificial Intelligence (AI), focusing on the implications for healthcare policy and practice in Norway, says Per Olav Vandvik, CEO of MAGIC.

The event is free, and we will accommodate 150 good colleagues (first come, first served) at Deichman in Bjørvika. In addition, we will broadcast digitally, so that everyone can experience the highlights from EULAR.

Read more about the Green Congress on Diakonhjemmet Hospital's website!

Here you will find the registration form!

Green Congress will be held for the fourth time, on June 21, 2024 at Deichman Bjørvika. As is tradition, the event opens with an environmental lecture. This year we have been fortunate enough to have CICERO researcher Bob van Oort join us.

Professor Nina Østerås, head of the Health Services Research Unit, gave an abstract presentation on the SAMBA study's eight-year link to the prosthesis registry. 

Marthe Kirkesæther Brun's doctoral thesis holds the key to preventing disease flare-ups in individuals with chronic inflammatory disease: The dosage of the biological drug infliximab should be adjusted over time, based on measurements of the drug's concentration in the blood.